Gout is a common rheumatic disease often characterized by swelling, redness, and intense pain in the big toe. Once thought to be an exclusive disease of the wealthy who overindulged in food and spirits, gout has become a royal pain for millions of Americans.
Search results for: Primary care
Information on New Drug Approvals and Medication Safety
Rheumatology-related drug safety, approvals, and what’s in the pipeline.
Unexpected Benefits of Bisphosphonates after Hip Fracture
Recent trials show this bisphosphonates can reduce subsequent hip fractures and mortality, while remaining cost effective.
Time Is Important Factor in E/M Coding
It is not unusual for rheumatologists to spend significant time during an office visit reviewing new and/or existing problems, modifying medications, counseling, and coordinating care, but is this additional time reimbursable?
A&R and AC&R Abstracts: Bisphosphonates
Want to learn more about bisphosphonates and fractures? Check out these abstracts from Arthritis & Rheumatism and Arthritis Care & Research.
Shortcomings and Promises of Genome-wide Association Studies
The outcomes of genome-wide association studies (GWAS) have not been what scientists expected, but researchers are developing new approaches to use revelatory GWAS information to identify genetic causal variants, predictors of treatment response, and future opportunities for genetic insight.
Antiphospholipid Antibody Testing Update
Successes, challenges, and controversies of diagnostic methods for APS
Quality Measurement Improves Rheumatology Outcomes
Innovations in health information technology can have significant impact
Drug Updates: Apremilast, Belimumab, and More
Information on new approvals and medication safety
Data Rich, Information Poor
Did you know that the health information stored by your practice could be one of your most valuable assets?
- « Previous Page
- 1
- …
- 126
- 127
- 128
- 129
- 130
- …
- 138
- Next Page »